Disability Benefits for Chronic Dermatitis

How SSA Evaluates Chronic Dermatitis

Dermatitis is inflammation of the skin that produces redness, itching, oozing, crusting, thickening, and cracking. The chronic and severe forms — including atopic dermatitis (eczema), severe contact dermatitis, and other persistent inflammatory skin conditions — can cover large areas of the body, break the skin open, and cause relentless itching that disrupts sleep and daily life. The Social Security Administration evaluates these under Blue Book listing 8.05, dermatitis.

Listing 8.05 requires:

• Extensive skin lesions — inflammation, thickening, or breakdown that is very serious, affects multiple body sites, or affects sites that seriously limit the use of more than one part of the body;
• that persist for at least three months despite continuing prescribed treatment.

The three-month, treatment-resistant standard is essential, because most dermatitis improves with topical steroids, moisturizers, and avoidance of triggers. SSA is looking for disease that remains extensive despite consistent, prescribed therapy — for example, widespread eczema that keeps breaking down across the hands, arms, and legs, or lesions in the skin folds and on the hands that limit the use of more than one part of the body. Because severe dermatitis often brings skin infections, sleep loss from itching, and the side effects of long-term treatment, SSA weighs the whole picture, and the impairment must last, or be expected to last, at least 12 months.

Medical Evidence SSA Needs for Chronic Dermatitis

Dermatology records are the backbone of the claim. SSA needs clinical notes at each visit describing the extent, location, and character of the lesions — redness, oozing, crusting, thickening (lichenification), and cracking — the body areas involved, and how the skin limits the use of affected parts. Clinical photographs strongly support the record, and patch testing or biopsy results help confirm the diagnosis and cause.

Proof of persistence despite at least three months of treatment is critical: document topical and oral steroids, immunosuppressants or biologic therapy, moisturizers, antihistamines, phototherapy, and trigger avoidance, along with your ongoing response, showing that extensive lesions continued.

Also document complications and their toll — recurrent skin infections, severe itching and the sleep loss it causes, and medication side effects — since these deepen the functional picture SSA considers.

Qualifying Through Your Residual Functional Capacity

Chronic dermatitis that does not meet the listing's extent requirement can still be work-limiting, and the residual functional capacity stage addresses it. Cracked, inflamed skin on the hands limits gripping, handling, and fine manipulation, and makes contact with water, chemicals, dust, and many materials intolerable — ruling out a wide range of jobs, including cleaning, food service, and manufacturing. Lesions on the feet and legs limit standing and walking.

Two less obvious factors carry real weight. First, relentless itching disrupts sleep, producing daytime fatigue and reduced concentration that translate into off-task time. Second, the need to avoid triggers sharply narrows the workplaces available, and flares are unpredictable, causing absences and time lost to skin care and infection treatment. Long-term medications add their own side effects.

For claimants 50 and older, a sedentary RFC that avoids irritants, combined with the medical-vocational grid rules, can support approval. Younger claimants generally prevail by documenting hand limitations, trigger sensitivity, and fatigue that preclude even sedentary work.

Tips for a Stronger Chronic Dermatitis Claim

Show that the disease is both extensive and stubborn.

• Ask your dermatologist to document the extent and location of lesions at every visit, not just adjust your cream.
• Provide dated photographs during flares, especially of your hands.
• Demonstrate that widespread lesions persisted despite at least three months of prescribed treatment — the core of listing 8.05.
• Report how itching disrupts your sleep and how flares affect your concentration and attendance.
• Document what substances and environments trigger your skin, since trigger avoidance narrows the work you can do.